Literature DB >> 15145998

Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.

J K Kim1, J Y Ahn, B H Lee, Y S Chung, S S Chung, O J Kim, W C Kim, J Y Joo.   

Abstract

BACKGROUND: Although stent assisted angioplasty is an effective treatment for coronary and peripheral arterial disease, its efficacy in intracranial arteriosclerotic disease has not been verified.
OBJECTIVES: To assess the radiographic and clinical outcome of stent assisted angioplasty for symptomatic middle cerebral artery (MCA) stenosis.
METHODS: We attempted stent assisted angioplasty in 14 patients with symptomatic high grade stenosis (>60%) on the proximal portion of the MCA, who had experienced either recurrent transient ischaemic attacks (TIAs) resistant to medical therapy or one or more stroke attacks. Patient records were analysed for angiographic characteristics, degree of stenosis, pre-procedural regimen of anti-platelet and/or anti-coagulation agents, use of devices, procedure related complications, pre-operative and post-operative single photon emission computed tomography (SPECT) findings, and clinical and radiographic outcomes.
RESULTS: Stent assisted angioplasty was successfully performed in 8 of 14 patients without any serious complications and unsuccessful in 2 of 14 patients due to the tortuous curve of the internal carotid artery siphon. Four patients had complications. Two patients had an arterial rupture; one patient was rescued by an additional stent and balloon tamponade, the other patient died. Complications in the other two patients included thrombotic occlusion and distal thrombosis. Residual stenosis was less than 50% in diameter in all the patients. All eight patients who underwent follow up cerebral angiography had no restenosis. Follow up SPECT showed improved perfusion in the affected MCA territory in all the tested patients with TIA and in one of three stroke patients. Using the modified Rankin Scale at follow up, four of five TIA patients and five of six stroke patients were assessed as functionally improved or having a stable clinical status.
CONCLUSION: Although the re-stenosis rate in stent assisted angioplasty seems to be better than in primary balloon angioplasty as reported previously, the complication rate is still high. Elective stenting is an alternative therapeutic method for the prevention of secondary ischaemic stroke in stroke patients with MCA stenosis, and seems to be a potentially effective but also hazardous therapeutic technique in patients with recurrent TIAs. This study indicates the need for randomised control trial data of this intervention. Additionally, long term follow up data and additional clinical experience are required to assess the durability of this procedure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145998      PMCID: PMC1739066          DOI: 10.1136/jnnp.2003.019570

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Acute and long-term outcomes of stenting in coronary vessel > 3.0 mm, 3.0-2.5 mm, and < 2.5 mm.

Authors:  I C Hsieh; C C Chien; H J Chang; M S Chern; K C Hung; F C Lin; D Wu
Journal:  Catheter Cardiovasc Interv       Date:  2001-07       Impact factor: 2.692

Review 2.  Racial distribution of intracranial and extracranial atherosclerosis.

Authors:  Huan Li; Ka Sing Wong
Journal:  J Clin Neurosci       Date:  2003-01       Impact factor: 1.961

3.  Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections.

Authors:  Pedro Lylyk; José E Cohen; Rosana Ceratto; Angel Ferrario; Carlos Miranda
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

4.  Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5 mm) coronary arteries.

Authors:  P Huang; T Levin; A Kabour; T Feldman
Journal:  Catheter Cardiovasc Interv       Date:  2000-02       Impact factor: 2.692

5.  Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke.

Authors:  Ka Sing Wong; Huan Li; Wynnie W M Lam; Yu Leung Chan; Richard Kay
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

6.  Improved cerebral perfusion after stenting of a petrous carotid stenosis: technical case report.

Authors:  R D Fessler; G Lanzino; L R Guterman; R S Miletich; D K Lopes; L N Hopkins
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

7.  Improved cerebral perfusion and metabolism after stenting for basilar artery stenosis: technical case report.

Authors:  N Uchiyama; S Kida; T Watanabe; J Yamashita; O Matsui
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

8.  Percutaneous transluminal angioplasty for symptomatic middle cerebral artery stenosis: long-term follow-up.

Authors:  Ju H Lee; Sun U Kwon; Jae H Lee; Dae C Suh; Jong S Kim
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

9.  Angioplasty for intracranial symptomatic vertebrobasilar ischemia.

Authors:  Daryl R Gress; Wade S Smith; Chris F Dowd; V Van Halbach; Randall J Finley; Randall T Higashida
Journal:  Neurosurgery       Date:  2002-07       Impact factor: 4.654

10.  Elective stenting of symptomatic middle cerebral artery stenosis.

Authors:  C R Gomez; V K Misra; M S Campbell; R D Soto
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

View more
  21 in total

1.  Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy.

Authors:  V Puetz; G Gahn; U Becker; D Mucha; A Mueller; N U Weir; B Wiedemann; R von Kummer
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

Review 2.  Stent-supported angioplasty for acute stroke caused by carotid dissection.

Authors:  Nazli Janjua; Adnan I Qureshi; Jawad Kirmani; Patrick Pullicino
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS.

Authors:  Zhongrong Miao; Ligang Song; David S Liebeskind; Liping Liu; Ning Ma; Yilong Wang; Dapeng Mo; Feng Gao; Xingquan Zhao; Kehui Dong; Dong Zhang; Peiyi Gao
Journal:  J Neurointerv Surg       Date:  2014-04-23       Impact factor: 5.836

4.  Effects of carotid or vertebrobasilar stent placement on cerebral perfusion and cognition.

Authors:  Roham Moftakhar; Aquilla S Turk; David B Niemann; Sayed Hussain; Sharad Rajpal; Thomas Cook; Madeleine Geraghty; Beverly Aagaard-Kienitz; Patrick A Turski; George C Newman
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

5.  Assessing success after cerebral revascularization for ischemia.

Authors:  John E Wanebo; Sepideh Amin-Hanjani; Cynthia Boyd; Terry Peery
Journal:  Skull Base       Date:  2005-08

6.  Middle cerebral artery stenosis: endovascular and surgical options.

Authors:  Jeffrey D Klopfenstein; Francisco A Ponce; Louis J Kim; Felipe C Albuquerque; Peter Nakaji; Robert F Spetzler
Journal:  Skull Base       Date:  2005-08

Review 7.  Management of symptomatic intracranial arterial stenosis: endovascular therapy.

Authors:  Mikael Mazighi; Alex Abou-Chebl
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

8.  Intracranial atherosclerosis: incidence, diagnosis and treatment.

Authors:  Jong S Kim; Dong-Wha Kang; Sun U Kwon
Journal:  J Clin Neurol       Date:  2005-04-30       Impact factor: 3.077

Review 9.  Current management of symptomatic intracranial stenosis: medical versus endovascular therapy.

Authors:  John B Weigele; Robert A Taylor; Scott E Kasner
Journal:  Curr Atheroscler Rep       Date:  2007-10       Impact factor: 5.113

Review 10.  Management of symptomatic intracranial atherosclerotic disease.

Authors:  Tudor G Jovin; Rishi Gupta; Michael B Horowitz
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.